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The microbiome plays an important role in lipid metabolism but how the introduction of probiotic
communities affects host lipid metabolism is poorly understood. Using a multidisciplinary approach we
addressed this knowledge gap using the zebrafish model by coupling high-throughput sequencing with
biochemical, molecular and morphological analysis to evaluate the changes in the intestine. Analysis of
bacterial 16S libraries revealed that Lactobacillus rhamnosus was able to modulate the gut microbiome of
zebrafish larvae, elevating the abundance of Firmicutes sequences and reducing the abundance of
Actinobacteria. The gut microbiome changes modulated host lipid processing by inducing transcriptional
down-regulation of genes involved in cholesterol and triglycerides metabolism (fit2, agpat4, dgat2, mgll,
hnf4a, scap, and cck) concomitantly decreasing total body cholesterol and triglyceride content and
increasing fatty acid levels. L. rhamnosus treatment also increased microvilli and enterocyte lengths and
decreased lipid droplet size in the intestinal epithelium. These changes resulted in elevated zebrafish larval
growth. This integrated system investigation demonstrates probiotic modulation of the gut microbiome,
highlights a novel gene network involved in lipid metabolism, provides an insight into how the microbiome
regulates molecules involved in lipid metabolism, and reveals a new potential role for L. rhamnosus in the
treatment of lipid disorders.
P
robiotics positively modulate the gut microbiota, and recent studies revealed that host microbiota can
modify host nutrient metabolism and energy balance both in germ free mice and zebrafish1–2. The gut
microbiota has been considered as one of the most important factors influencing host metabolism, energy
and lipid metabolism, fat distribution, insulin sensitivity and growth performance3.
Considering the increasing number of diseases associated with lipid metabolic disturbances, several studies
have focused on the ability of probiotics, mainly Lactobacillus and Bifidobacterium, to decrease serum lipid
content (e.g. cholesterol and triglycerides)1,3. Numerous hypotheses have been proposed for the mechanisms
involved in the reduction of cholesterol by probiotics in the gut and their impact on the energy of the host4–5.
In general, the lipidmetabolic pathway involves a considerable number of genes which regulate lipid synthesis,
traffic, storage and homeostasis. Fish andmammals use triglycerides (TAG) and cholesterol derived from the diet
as the main source of energy6. In eukaryotes, both the glycerol phosphate and the monoacylglycerol pathways
represent the two main processes to resynthesize TAG7. TAG synthesis via the glycerol phosphate pathway
mainly takes place in the liver and adipose tissues8. Briefly, this process involves the acylation of glycerol 3-
phosphate by glycerol-3-phosphate acyltransferase (GAPT) and the conversion of diacylglycerol (DAG) into
TAG by diacylglycerol acyltransferase (DGAT)8–10.
In order for the intestine to absorb TAG, TAGmust first be hydrolyzed trough a three-step process catalyzed by
adipose triglyceride lipase, hormonesensitive lipase, and monoacylglycerol lipase (MGLL)11–12. In particular,
recent studies showed that MGLL is located in villi, enterocytes and adipocytes and is involved in the final step
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of TAG hydrolysis, specifically, hydrolyzing monoglycerides to free
glycerol and fatty acids13–15. MGLL is also involved in the regulation
2-arachidonoylglycerol signalling16. Free glycerol and fatty acids are
then taken up by the enterocytes, resynthesized into new TAG and
either incorporated into nascent chylomicrons for secretion or stored
as lipid droplets (LDs)16–17.
The monoacylglycerol pathway takes place in the intestine;
the biosynthesis of TAG starts with the formation of bonds
between monoacylglycerol and fatty acyl–CoA, catalyzed by mono-
acylglycerol acyltransferase, forming DAG18. Later, DGAT catalyzes
a reaction that produces TAG fromDAG and fatty acyl-CoA18. TAG
together with sterol esters and phospholipids form LDs, which are
cytosolic structures located in numerous cell types including enter-
ocytes, which play a crucial role in the energy homeostasis in all
eukaryotes19.
On the other hand, free cholesterol from biliary or dietary origin is
absorbed by the enterocytes and incorporated into chylomicrons as
cholesterol ester (CE), then transported into the lymphatic system6.
The present study aimed at evaluating the effect of supplementa-
tion of the probiotic L. rhamnosus on the gut microbial community
and lipid metabolism of zebrafish (Danio rerio).
In order to achieve this, a wide network of genes involved in lipid
metabolism were examined, and the effect of L. rhamnosus on intest-
inal epithelial structures, total body cholesterol, TAG and non-polar
fatty acids and zebrafish larval growth was investigated.
Results
Probiotic modulation of the digestive tract microbiome. High-
throughput sequence analysis of bacterial 16S rRNA V3 region was
conducted on samples at 6 dpf. The analysis revealed a highly diverse
microbiota with a total of 200 thousand unique reads (with an average
length of 166.0 6 6.5 bp), representing 218 OTUs, from over 1.2
million raw reads. Using default parameters, a de novo UCHIME
algorithm20 was used to identify potential chimeric sequences, which
accounted for 5.1% of the total sequences. The alpha rarefaction plot
of observed species reached a saturation phase at approximately
169 OTUs indicating that adequate sequence coverage was obtained
to reliably describe the full diversity present in the samples
(Figure 1A). This was verified by the Good’s coverage estimation
values of .99.9% (Table 1). The bacterial branch distance, which
measures the complete phylogenetic diversity represented within a
community21, demonstrated a significantly lower microbial diversity
in the probiotic group (2.34 6 0.14) compared to control group (2.65
6 0.16) (P, 0.05) (Table 1). In order to evaluate relationships among
samples based on differences in phylogenetic diversity, two-dimensional
principal coordinate analysis (PCoA) plots were calculated from
weighted UniFrac distances for the evaluation of the community
composition22 (Figure 1D) and Bray-Curtis metrics were used for the
estimation of the dissimilarity among samples23 (Figure 1E). Both PCoA
plots show clustering of the replicates from the probiotic treatment
away from the control samples, suggesting that the probiotic
modified the bacterial communities in a characteristic direction.
In general, the bacterial communities in both treatments were domi-
nated by three phyla: Firmicutes, Proteobacteria and Actinobacteria.
The distinguishable separation of bacterial communities found in
PCoA was accompanied with differences in the composition of the
gut microbiota. A small proportion of the reads were identified as
belonging to the Bacteriodetes (4.3%), Fusobacteria (2.0%), and
Planctomycetes (1.6%) phyla in the control, which were considerably
less abundant in the probiotic group (where Bacteriodetes and
Fusobacteria were not detected and Planctomycetes 5 0.3% of the
reads) (Figure 1B), and higher relative abundance of Firmicutes was
observed in the probiotic group (P , 0.05, Figure 1B). Most OTUs
were resolved to class-level, others by order and some to genus level
(Figure 1B–C). Firmicutes were dominated by the class Bacilli, with this
class more abundant in the treated group than the control (P, 0.05).
Lactobacillus spp. were significantly more abundant in the probiotic
treated larvae (accounting for 33.0% of the total reads) than the control
larvae (accounting for 8.1% of the reads) (P , 0.05), BLAST results
identified the dominant lactobacilli as L. rhamnosus (NR-102778) in
the probiotic treated samples, accounting for 100% of the lactobacilli
reads, whereas lactobacilli reads from the control comprised
Lactobacillus reuteri and L. rhamnosus. The abundance of reads
assigned to the Streptococcus genera did not differ significantly between
the groups, but BLAST revealed that the species composition of this
genera differed between the treatment groups: Streptococcus thermo-
philus (NR- 074827) dominated the probiotic samples and the control
samples were dominated by an uncultured Streptococcus sp. most clo-
sely related to Streptococcus sanguinis (94% alignment similarity). A
core microbiome of OTUs, detected in both treatment groups, was
identified and comprised 27 OTUs (Figure 1F); these were the
Streptococcus, Pseudomonas, Lactobacillus, Acidovorax, Actinomyces,
Enhydrobacter, Ochrobactrum, Phenylobacterium, Acinetobacter, Escheri-
chia, Aminobacter, Corynebacterium and Agrobacterium genera and 14
additional OTUs which could not be accurately identified at the genus
level. Five OTUs were unique to the fish treated with the probiotic
(Janthinobacterium, Gluconacetobacter, Faecalibacterium and two
unidentified OTUs) and the 11 OTUs were uniquely detected in the
control fish (Chryseobacterium, Sneathia, Mycobacterium, Kocuria,
Hymenobacter, Finegoldia and five unidentified OTUs) (Figure 1F).
L. rhamnosus affects the expression of genes involved in lipid
metabolism. The high-throughput sequencing results evidenced a
change in gut microbiota community exposed to L. rhmanosus. In
order to gain further insight, we next wanted to evaluate effect of
microbiota modulation on lipidmetabolism, and thus the expression
of genes related with lipid pathways were assessed.
At hatching, when probiotic administration was not yet supplied,
the gene expression levels of agpat4, a gene encoding for an enzyme
involved in the conversion of lysophosphatidate to phosphatidate in
the glycerol phosphate pathway24, was almost undetectable
(Figure 2A). During larval development of the control fish this gene
reached the highest level of expression at 96 hpf and significantly
decreased at 6 and 8 dpf (the last stage analyzed in the present study).
A similar trend was recorded in L. rhamnosus treated fish with the
highest levels of agpat4 gene expression detected at 96 hpf and sig-
nificantly lower levels at 6 and 8 dpf. Comparison between the two
experimental groups revealed a significant down-regulation of
agpat4 in the probiotic treated larvae with respect to the control
group, in all the developmental stages analyzed (96 hpf, 6 dpf and
8 dpf).
The gene expression analysis of dgat2, a gene encoding for a pro-
tein that catalyzes a reaction which produces TAG from DAG and
fatty acyl-CoA8, was clearly detectable at hatching (Figure 2B); at
96 hpf a significant decrease occurred and a successive significant
increase at 6 dpf and 8 dpf was observed. In treated larvae, the lowest
dgat2 level was detected at 96 hpf, gradually increasing at 6 dpf and
reaching the highest level at 8 dpf. The comparison between control
and treated groups evidenced similar levels at 96 hpf, while signifi-
cantly lower levels were observed in the probiotic treated group at 6
and 8 dpf.
The analysis of mgll expression levels, which encodes for a serine
hydrolase that preferentially hydrolyses monoacylglycerols [e.g. 2-
arachidonoylglycerol; (2-AG)] to free fatty acid and glycerol14, evi-
denced its presence at hatching (Figure 2C). In the control, the
expression was significantly higher at 96 hpf, significantly decreased
at 6 dpf and a successively significant increase occurred at 8 dpf. The
same trend was observed in treated larvae at all the developmental
stages analyzed. The comparison between the two experimental
groups revealed that probiotic treatment induced significantly higher
expression at 96 hpf and 6 dpf while no difference was apparent at
8 dpf.
www.nature.com/scientificreports
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The analysis of hnf4a, a gene encoding for a protein implicated in
the metabolism of cholesterol, fatty acids and amino acids25, evi-
denced its presence at hatching, and in both control and probiotic
treated groups peaked at 96 hpf, and subsequently significantly
decreased at 6 dpf reaching the lowest level at 8 dpf (Figure 2D).
Compared to the control, hnf4a gene expression was down regulated
by the probiotic at 6 dpf.
The fit2 gene, encoding for a protein involved in fat storage19,
transcript analysis in the control group showed the highest level at
hatching; similar levels were maintained at 96 hpf followed by a
significant decrease at 6 and 8 dpf (Figure 2E). In treated larvae,
higher levels were observed at 96 hpf and 8 dpf while at 6 dpf the
lowest levels were detected. Comparing the levels of fit2 gene between
the treatments, lower levels were observed at 96 hpf and 6 dpf in the
probiotic treatment.
The analysis of the expression of scap (Figure 2F), encoding for
Cleavage Activation Protein which activates SREBPs which regulate
the transcription of genes involved in uptake and synthesis of de novo
cholesterol and fatty acids26, evidenced highest levels at hatching. In
both experimental groups a significant decrease of gene expression
Figure 1 | Digestive tract bacterial community analysis of 6 dpf zebrafish larvae. (A) Alpha rarefaction plot of observed species. (B) Relative abundance
of reads assigned to phyla. (C) Stacked bar chart representing the relative abundance of bacterial phylum and classes. (D) and (E) Principal
coordinates analysis (PCoA) plots using Bray-Curtis metric and weighted Unicfrac distances, respectively. (F) Unique and shared OTUs (at the level of
genera) present in the treatment groups.
www.nature.com/scientificreports
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was detected at all stages analysed compared to the levels at hatching.
No significant differences were observed between the control and
probiotic groups at any of the developmental stages analyzed.
Finally the analysis of cck, which encodes for a peptide hormone
responsible for gallbladder contraction and pancreatic enzyme
secretion27, was clearly detectable at hatching (Figure 2G); at 96 hpf
a significant decrease was detected and a successive significant increase
at 6 dpf was observed in the control group compared to the time of
hatching. Finally, at 8 dpf, the gene expression level reached the same
level of that at the time of hatching. The same trend was observed in
treated group. The comparison between control and treated groups
evidenced significantly higher levels in the probiotic treated group in
all the developmental stages analyzed (96 hpf, 6 dpf and 8 dpf).
Modulation of microbiota decreased the total body cholesterol
and triglyceride levels. Triglycerides and cholesterol derived from
the diet are used from both fish and mammals as the main source of
energy which can be released rapidly on demand6. TAGs represent
the major source of lipid storage and cholesterol and are an
important component of cell membranes; they are also the
precursor molecules for the synthesis of steroid hormones, bile
salts and vitamin D28–29. However, it has been reported that excess
TAG storage as well as high serum cholesterol levels cause several
metabolic disorders including Type 2 diabetes, hypertension and
atherosclerosis30. To gain further insight into the probiotic effects
on lipid metabolism, the zebrafish total cholesterol and TAG
content were evaluated. The High Performance Liquid Chroma-
tography (HPLC) analyses performed on total body samples
evidenced that zebrafish treated with L. rhamnosus had
significantly lower levels of total cholesterol (0.083 6 0.006 mg/
mg) and TAG (0.040 6 0.003 mg/mg) compared to the total
cholesterol (0.131 6 0.014 mg/mg) and TAG (0.088 6 0.010 mg/
mg) levels in the control group (P , 0.05) (Table 2).
Ultrastructural analysis by Transmission Electron Microscopy
(TEM) revealed longer enterocytes and microvilli heights in the
intestine of probiotic treated zebrafish. At 6 dpf the alimentary
canal of zebrafish comprises the mouth, pharynx, esophagus,
intestinal bulb, mid-intestine, posterior intestine and anal opening.
The yolk is completely resorbed31. In the intestinal bulb, the rostral
region of the gut, the lumen was greatly expanded and the epithelial
layer was arranged into broad, irregular folds. The intestine of
control group had an undamaged epithelial barrier and no signs of
degradation (Figure 3A). The intestines exposed to the probiotic L.
rhamnosus had an intact epithelial barrier, lack of cell debris in the
lumen and no signs of damage (Figure 3B). At this stage the intestine
consisted mainly of uniform, columnar, polarized epithelia, with an
apical brush border, lateral cell border, and basal basement
membrane. Both in control and treated groups (Figure 3C–D),
columnar-shaped enterocytes were joined apically through a
complex set of junctional complexes (tight junctions, adherens
junctions and desmosomes) that restrict the movement of
membrane components between apical and basolateral cellular
domains, and serve as a barrier to the paracellular space through
which luminal contents may otherwise enter the organism
(Figure 3E). In the probiotic treated larvae the enterocytes lengths
were significantly higher (42.246 1.78 mm) compared to the control
(34.64 6 2.06 mm) and significantly longer microvilli on the apical
surface were observed in L. rhamnosus exposed larvae (1.21 6
0.09 mm) with respect to the control (1.06 6 0.08 mm) (P , 0.05)
(Figure 3F–G). The enterocyte‘s apical cytoplasm contained copious
spherical mitochondria and endoplasmic reticulum. In addition,
lipid accumulations were present in the apical and basal cytoplasm
of both control and treated groups (Figure 3 C–D; H–I). These
accumulations were determined to be lipid droplets by their
uniform interior, association with endoplasmic reticulum and
mitochondria, and presence of a bounding monolayer membrane.
In probiotic treated larvae the diameter of the lipid droplets (2.37 6
0.37 mm) was significantly smaller compared to the control (4.10 6
0.40 mm) (P , 0.05). Supplemental material: see also supplemental
Figure S3 (A) for enterocyte lengths (related to Figure 3 C–D), Figure
S3 (B) for lipid droplet diameter (related to Figure 3 C–D; H–I), and
Figure S3 (C) for microvilli lengths (related to Figure 3 F–G).
In vivo non-polar fatty acids localization with BODIPY 505/515
staining revealed accumulations in the gallbladder and intestine
of probiotic treated fish. Teleosts and mammals have complex
digestive physiologies but share a high degree of anatomical
similarity32. Zebrafish, like humans, use TAG as a major source of
lipid, and in order for the intestine to absorb TAG, processing by
digestive enzymes and bile is required33. Bile and enzymes pass from
the gallbladder and arrive to the intestinal lumen where TAG are
emulsified and form micelles and finally, free fatty acids (FFAs) and
monoacylglycerols are taken up by intestine34. It has been
demonstrated that FFAs have an important role in gallbladder
secretion35. We used BODIPY 505/515 (borondipyrromethene
fluorescent moiety) staining as a non-invasive in vivo method in
order to visualize the dynamics of non-polar fatty acids in living
tissues by confocal microscopy. Imaging revealed similar green
fluorescence intensity in the intestine of both control (320 6 34
a.u.) (Figure 4 A–B) and probiotic treated zebrafish larvae (338 6
52 a.u.) at 6 dpf (Figure 4 C–D) (P , 0.05). On the contrary,
probiotic treated larvae exhibited significantly higher fluorescent
signal in the gallbladder (535 6 66 a.u.) with respect to the control
(340 6 53 a.u.) (P , 0.05) highlighting an accumulation of non
polar-fatty acids.
Supplemental figure: Figure S4 (E) shows graph with statistical
difference of intestinal fluorescence of both control and treated lar-
vae (Figure 4 A–B–C–D).
Treatment with L. rhamnosus improves the growth of zebrafish
larvae. Since we reported compelling evidence of gut community
modulation and in turn lipid metabolism modulation after
administration of L. rhamnosus, by measuring total larval length
and wet weight, we sought to determine if these changes impacted
the growth of zebrafish larvae. At 96 hpf no significance differences
were observed in terms of length and weight in both control (length
3.3 6 0.17 mm; weight 0.43 6 0.07 mg) and treated (length 3.4 6
0.11 mm, weight 0.4 6 0.08 mg) larvae (P . 0.05). At 6 dpf no
significant difference of larval length was observed between control
larvae (3.5 6 0.16 mm) and larvae exposed to L. rhamnosus (3.6 6
0.18 mm) (P . 0.05). Despite this, a significant increase of wet
Table 1 | Alpha diversity metrics of observed species, phylogenetic diversity (PD), Chao1, Shannon’s diversity and Good’s coverage of
zebrafish larvae of 6 dpf (mean 6 s.d.; n 5 3)
Observed species Chao1 Shannon Phylogenetic distance Good‘s coverage
Control 195.1 6 9.2 209.3 6 12.2 5.57 6 0.37 2.74 6 0.14b 0.9992 6 0.0002
Probiotic 194. 5 6 1.5 206.5 6 1.1 5.92 6 0.14 2.45 6 0.05a 0.9994 6 0.0001
Values with different superscripts, within the same column, are significantly different at P , 0.05.
www.nature.com/scientificreports
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weight was observed at 6 dpf in the probiotic supplemented group
(1.19 6 0.09 mg) compared to the control group (0.9 6 0.1 mg). At
8 dpf a significant increase of total length (3.9 6 0.12 mm)
concomitant with a significant increase of wet weight (1.37 6
0.13 mg) was apparent in zebrafish larvae treated with the
probiotic compared to the length (3.6 6 0.21 mm) and wet weight
Figure 2 | L. rhamnosus treatment modulates expression of genes involved in lipid metabolism. qRT-PCR analysis. Relative agpat (A), dgat2 (B),mgll
(C), hnf4a (D), fit2 (E), scap (F), cck (G) gene expression normalized against b-act and arp, in pools of 15 zebrafish larvae from control and probiotic
groups collected at hatching (H), 96 hpf, 6 dpf and 8 dpf. Assays were performed in triplicate. Values with different superscript letters are significantly
different (P , 0.05).
www.nature.com/scientificreports
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(1.07 6 0.08 mg) detected in control group (P, 0.05) (Figure 5A–
B). In all stages examined the viable larvae observed in both control
and treated groups were 95–98%.
Discussion
In the current study, the administration of L. rhamnosus induced
changes to the microbial composition of the zebrafish digestive tract.
The probiotic treatment reduced the presence of some genera which
contain potential pathogens (e.g.Mycobacterium) and enhanced the
abundance of reads assigned to the class Bacilli. Reads from the
Lactobacillus genera were significantly elevated by the probiotic lar-
vae and in addition the probiotic enhanced the presence of another
lactic acid bacteria, Streptococcus thermophilus. This finding is in
agreement with the previous study on 6-month old zebrafish fed
dietary L. rhamnosus which demonstrated that the probiotic popu-
lated the intestinal tract and elevated the abundance Streptococcus
thermophilus36. Streptococcus thermophilus and lactobacilli (e.g.
Lactobacillus delbrueckii subsp. bulgaricus) are known symbionts
as observed from their interactions as starter cultures in dairy pro-
ducts; Streptococcus thermophilus is suggested to provide folic acid
and formic acid to the lactobacilli which in turn provides a source of
amino acids37. The present study, and that of Gioacchini et al.36,
would suggest that a similar symbiotic relationship may occur
between L. rhamnosus and S. thermophilus in the digestive tract of
zebrafish. Indeed, some strains of lactobacilli and streptococci have
been reported to have symbiotic effects in mammals, subsequently
reducing hepatic cholesterol levels in rats fed a fat- and cholesterol-
enriched diet38.
The in vivo mechanisms of the gut microbiota which influence
host dietary lipid metabolism are still unknown, however Semova
et al.1 identified that colonization of the zebrafish gut with Firmicutes
promotes epithelial absorption and is involved in host energy balance
of zebrafish larvae. Further studies are required to enhance our
understanding of the roles that gutmicrobes play in lipidmetabolism
and specific studies should elucidate the extent to which the observed
effects in the present study are L. rhamnosus-specific; for example, it
is not apparent from the present study if the host effects could be
driven by overall changes, elevations in microbial load or whether
other probiotic species are capable of driving these effects.
Microvilli and enterocyte height are directly correlated with the
gut function and health of the host; an increase of microvilli and
enterocytes heights provide increased absorptive surface area. Our
TEM analysis highlighted increased microvilli and enterocyte
heights, suggesting that L. rhamnosus is able to expand intestine
structures. These findings are in agreement with previous probiotic
studies39–40 and are likely to contribute towards the improved growth
performance of the zebrafish larvae in the present investigation.
Additionally, it has been observed that gutmicrobiota can ameliorate
the absorption of nutrients and minerals, in particular calcium41. In
the intestine, microbial production of SCFAs, which may have been
elevated by the probiotics, can decrease the pH which indirectly
increases the solubility of minerals and subsequently their absorp-
tion42. Furthermore, the symbiotic relationship between L. rhamno-
sus and S. thermophilus and their ability to generatemetabolites, such
as SCFAs, which can allow the host, especially the enterocytes, to use
energy from the diet in a more efficent way. Is well known that
enterocytes obtain a large proportion of their energy from the oxida-
tion of luminally derived SCFAs and absorbed SCFAs not utilised by
enterocytes may also provide additional energy at the systemic level
for other cell types43. These events could positively affect the host,
leading to an increase in host growth44.
Further, possible modulation of the expression of genes involved
in lipid metabolism may also have contributed towards improved
growth.
L. rhamnosus administration and the relative modulation of the
gut microbiota was able to induce transcriptional changes to a suite
of genes involved in the synthesis, transport, storage and homeostasis
of lipids, in particular, cholesterol and TAG. TAG biosynthesis is
catalysed by AGPAT4 and DGAT2 enzymes and recent studies in
mice and rats showed that their inhibition decreases TAG syn-
thesis45–47. In this study, agpat4 and dgat2 transcription were both
decreased by L. rhamnosus. Furthermore these transcriptional
changes induced by L. rhamnosus administration reflected a signifi-
cant reduction in TAG content observed in treated larvae. TAG,
together with sterol esters and phospholipids, form LD and recent
studies on mouse liver and muscle evidenced that knockdown of fit2
significantly decreases LD accumulation48. Recently, it was demon-
strated that fit2 expression is ubiquitous in all zebrafish tissues49. In
the present study, the lower level of fit2 mRNA found in probiotic
treated larvae was concomitant with the reduction in size of LD in the
intestine of treated larvae, evidenced by TEM analyses. This result is
consistent with a study showing that fit2 knockdown in zebrafish
resulted in a decrease of LD in the liver and intestine49.
Recently, Guo and co-workers50 demonstrated that stimulation of
lipolysis may break down large LDs into smaller LDs, in order to
increase the surface area available for lipases, which are able to
hydrolyze TAG. We observed a reduction in triglyceride content
and a decrease of LDs accumulation, suggesting that L. rhamnosus
affects the expression of TAG metabolism related genes (agpat4,
dgat2 and fit2) and may stimulate lipolysis. Our findings on LDs
accumulation are also consistent with a previous study in Solea sene-
galensis which showed the ability of a probiotic from the
Alteromonadaceae family to inhibit intestinal LDs accumulation51.
Interestingly, BODIPY 505/515 staining evidenced an intense fluor-
escent signal in the gallbladder of probiotic treated larvae, indicating
that this non-polar lipid can be absorbed by the intestine, succes-
sively taken up by the liver and secreted into the gallbladder, through
hepatobiliary transport.
The enhancement of fluorescence in the gallbladder prompted us
to speculate an accumulation of non-polar fatty acids and/or other
hydrophobic region that constitute most of the lipids. The bile in the
gallbladder is composed by several molecules and among these, bile
acids and bile alcohol, composed by both hydrophobic and hydro-
philic regions, are the most abundant molecules in the bile of verte-
brates52. Zebrafish bile contains bile alcohol52. The synthesis of bile
alcohol is not thought to be influenced by diet, rather mostly regu-
lated by the gut microbiota, which possess unique enzymes involved
in deconjugation, oxidation and esterification of bile alcohol53; thus,
this result could indicate an increase of non-polar lipid bile fraction
Table 2 | L. rhamnosus administration affects whole larval cholesterol and triglycerides content
Parameter
Control Probiotic
Value Value P-value
Cholesterol (mg/mg DNA) 0.131 6 0.014 0.083 6 0.006* 0.04
TAG (mg/mg DNA) 0.088 6 0.010 0.040 6 0.003* 0.02
Probiotics significantly decrease the content of cholesterol and triglyceride (TAG) in 6 dpf zebrafish larvae (pools 300 mg of larvae). Data are the mean 6 s.d. Data have been normalized with DNA content.
Values with asterisk are significantly different (P , 0.05).
www.nature.com/scientificreports
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production as a result of the probiotic activity, as previously demon-
strated by Pavlovic´ et al.54
It has been evidenced that free fatty acids stimulate CCK, which
induces the contraction of the gallbladder to release bile into the
intestine and solubilize lipids into micelles that are hydrolized by
pancreatic lipase35. Our results demonstrate an up-regulation of
cck gene expression levels concomitant with a higher content of
non-polar fatty acids in the gallbladder after the probiotic supple-
mentation. This could indicate increased bile production and hepa-
tobiliary function, reduced bile secretion into the intestine, altered
intestinal motility rates, improved the enterohepatic cycling of bile
acids and/or bile transportation55–56.
Recently, MGLL has been described as one of the lipases involved
in the final step of TAG hydrolysis57. Our results showed an up-
regulation of mgll gene expression level that reflected the lower
TAG content observed, consistent with the presence of non-polar
fatty acids (as a probable result of the breakdown of triglycerides) in
the gallbladder after probiotic supplementation, which indicates the
role of the digestive tract microbiota in the modulation of non-polar
fatty acids metabolism.
In addition, recent studies showed that hnf4a knock-down reduces
cholesterol content58–59. Our data indicate that L. rhamnosus treat-
ment decreases the expression of the hnf4a gene, and therefore these
results suggest that the modulation of gut microbiota, by inducing
transcriptional changes, modulates cholesterol metabolism. The
down-regulation of hnf4a after probiotic supplementation reflected
a lower cholesterol content in the larvae. These findings are in agree-
ment with a study which demonstrated cholesterol-lowering action
by probiotics inmammals60. Cholesterol homeostasis is controlled by
scap which plays an essential role in maintaining and controlling de
novo synthesis of cholesterol, and therefore, is responsible for endo-
genous biosynthesis61. The maintenance of scap levels in the current
study, concomitant with the decrease of cholesterol in treated larvae,
suggests that the cholesterol reduction is not related with lower de
novo synthesis but with its consumption.
Themodulation of cholesterol metabolism evidenced in our study,
could be due to the production of SCFAs as final products of bacterial
activity in the digestive tract: SCFAs can decrease lipid levels in the
blood by blocking the synthesis of hepatic cholesterol and transfer-
ring plasma cholesterol to the liver4,62.
This study clearly evidenced a novel role of L. rhamnosus on the
modulation of the microbiota community in the zebrafish digestive
tract. The digestive tract microbiome changes in response to the
probiotic supplementation modulated the expression of a network
of genes involved in the physiological control of lipogenesis, a con-
comitant reduction of total body cholesterol and triglycerides, an
increase of non-polar fatty acids, an improvement of the intestinal
epithelium structures (i.e. microvilli and enterocytes) and a reduc-
tion in enterocyte LDs, together with an increase in growth of pro-
biotic treated zebrafish larvae.
The findings we report provide a novel gene network through
which L. rhamnosus acts and, by inducing transcriptional changes,
modulates lipid metabolism. Probiotic L. rhamnosus also i) modu-
lates gut microbial composition, ii) increases FAs concentration, and
iii) expands the absorptive surface of the intestinal epithelium by
increasing microvilli and enterocytes heights. Since the zebrafish
has become an established vertebrate model for a wide range of
human diseases with particular strengths for biomedical research,
the results discussed here suggest a possible use of L. rhamnosus
for improving lipid metabolic disorder.
Methods
Animals and probiotic administration. Adult female and male zebrafish (D. rerio)
were purchased from Acquario di Bologna (Italy) and acclimatized to the laboratory
conditions (27.0 6 0.5uC under a 12512 h light5dark photoperiod). Pairs were
spawned individually and larvae were raised under a 12512 h light5dark cycle at
27uC. Embryos were collected and after hatching were divided into a control group
and a probiotic-treated group. Larvae were fed a commercial diet (JBL flakes,
Germany) consisting of 43.00% crude protein, 8.30% crude fat, 8.10% ash, 1.9% fibre
and 8.00%moisture content. The probiotic treatment consisted of the administration
of L. rhamnosus IMC 501H (C025396A; Synbiotec, Camerino, Italy) via the rearing
water at a concentration of 106 colony-forming units (CFU) according to previous
studies36,63–65.
Figure 3 | Transmission Electron Microscopy (TEM) shows the
ultrastructure of the intestine in control and probiotic treated zebrafish.
Thin section (80 nm) of 6 dpf zebrafish showing the epithelial layer
arranged into broad, irregular folds (A). Intact epithelial barrier, lack of cell
debris in the lumen and no signs of damage in larvae exposed to probiotic
L. rhamnosus (B). Electron micrographs showing uniform, columnar,
polarized epithelia, with an apical brush border in control (C) and
probiotic treated groups (D). Higher magnification of junctional
complexes (E). Microvilli on the apical surface and copious spherical
mitochondria in the enterocyte cytoplasm of control (F) and treated larvae
(G). Higher magnification of the lipid droplets in the enterocytes of
control larvae (H) and in the probiotic treated intestine (I). BB: brush
border; L: lumen; M: mitochondria; *: nucleus; arrows: lipid droplets.
Scale bar: 5 mm in (A, B); 10 mm in (C, D); 500 nm in (E), 1 mm in (F, G);
2 mm in (H, I). (See also Figure S3).
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The experiment was set up in triplicates, with three control tanks and three pro-
biotic tanks and from each tank a pool of larvae was collected. The experiment was
repeated three times.
Both control and probiotic groups were fed twice a day. At hatching, 96 hpf, 6 dpf
and 8 dpf, larvae were euthanised using MS222 (100 mg L21) (Sigma-Aldrich) and
stored at 280uC for real time PCR analyses. At 96 hpf, 6 and 8 dpf larvae were
sampled for morphometric analyses. Since at 6 dpf, molecular analysis revealed sig-
nificant changes of expression of all genes analysed, the high-throughput sequencing,
HPLC, TEM and BODIPY staining were performed at this stage of development.
Larvae from all stages, both control and the treated group were sampled 18 hrs post
meal, at 8 am. All procedures involving animals were conducted in accordance with
the Italian law on animal experimentation and were approved by the Ethics
Committee of Universita` Politecnica delle Marche (Prot #63/INT/CESA12-16).
RNA extraction and cDNA synthesis.Total RNAwas extracted from 15 whole larvae
per tank using an RNAeasyH minikit (Qiagen, UK) according to Maradonna et al.66.
Real time PCR. PCRs were performed with the SYBR greenmethod in an iQ5 iCycler
thermal cycler (Bio-Rad laboratories). Triplicate PCRs were carried out for each
sample analyzed. The reactions were set following Maradonna et al.66. The data
obtained were analyzed using the iQ5 optical system software version 2.0 (Bio-Rad
laboratories). Modification of gene expression is reported with respect to the control
sample. The primer sequences for actb, rplp, mgll, hnf4a, fit2, scap and cck were
designed using Primer3 (210 v. 0.4.0), primers for agpat4 and dgat2 were taken from
Her et al.67.
The primer sequences are: agpat4 forward TGCTGAAAACTCAGTTGCTG,
agpat4 reverse AGTAACCCAGTCTGCAGTTG, dgat2 forward
Figure 4 | BODIPY 505/515 staining evidenced an accumulation of non-polar fatty acids in probiotic treated gallbladder. Representative fluorescent
images of live 6 dpf zebrafish soaked in BODIPY 505/515 for 1 hour. Images revealed green fluorescence in the intestine in both control (A–B) and
probiotic treated groups (C–D). Probiotic treated larvae exhibited higher fluorescent signal in the gallbladder (D). Red asterisk: gallbladder; red arrow:
intestine. Scale bar: 500 mm. (See also Figure S4).
Figure 5 | L. rhamnosus administration increased larvae total length and body weight. Total length (A) and wet weight (B) of zebrafish larvae from
control and probiotic groups collected at 96 hpf, 6 dpf and 8 dpf. Data are the mean 6 s.d. Asterisk indicates significant differences (P , 0.05).
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TTCCGGTGTCAAAAAGGGCT, dgat2 reverse CAGCAGCAAAGAGCAAGCAA,
mgll forward CGAGAGGCCGCAGGATTTTA, mgll reverse
TGAGTTTAGGAGCCAAGCG, hnf4a forward ACGGTTCGGCGAGCTGCTTC,
reverse hnf4a TCCTGGACCAGATGGGGGTGT, fit2 forward
CTGGTCTCCCTCCACAGCCGA, fit2 reverse ACACCAGCTGCCCTCCGCTT,
scap forward GCTGTTACCCTCTGCTGAAG, scap reverse
TGAAACCGCTGCCTTGAC, cck forward CGCCTGCTGGACAAATCAAC, cck
reverse TGCGGTATGAGCCTTTGGTT, rplp forward
CTGAACATCTCGCCCTTCTC-39, rplp reverse TAGCCGATCTGCAGACACAC,
b-act forward GGTACCCATCTCCTGCTCCAA, b-act reverse
GAGCGTGGCTACTCCTTCACC.
Digestive tract microbiome analysis
DNA extraction and PCR. DNA was extracted from 100 mg of the
sterilized organisms, after a 30 min lysozyme incubation (50 mg
mL21) at 37uC, using a QIAampH Stool Mini Kit (Qiagen, Crawley,
UK) according to the manufacturer’s instructions, with some
modifications in the cleanup and precipitation steps according to68.
Briefly, after the removal of proteins, 460 mL of extract product was
added to an equal volume of ice-cold Tris-buffered phenol solution,
left to stand on ice for 10 min, then washed twice with an equal
volume of chloroform, and centrifuged for 5 min at 3,000 g. The
upper aqueous layer was isolated and the DNA precipitated
overnight using an equal volume of ice-cold isopropanol and 10%
sodium acetate, before centrifugation at 14,000 g for 30 min at 4uC.
The DNA pellet was washed twice using 300 mL of 70% molecular
biology-grade ethanol, before air drying for 5 min, and resuspension
overnight at 4uC in 30 mL sterile water. The DNA concentration was
determined at 260 nm using a NanoDropTM 1000 spectro-
photometer (Thermo Scientific Ltd, DE, USA). All reagents used
were molecular grade, purchased from Sigma-Aldrich (UK).
PCR amplification of the 16S rRNAV3 region was conducted with
a nested PCR strategy69, the external PCR was carried out using
primers Eub8F (59-AGAGTTTGATCMTGGCTCAG-93)70 and
984yR (59-GTAAGGTTCYTCGCGT-3)71; the internal PCR was
conducted using the primers P1F (59-CCTACGGGAGGCAGC-
AG-39 1 GC clamp) and P2R (59-ATTACCGCGGCTGCTGG-
39)72. Two mL of DNA template was used in both reactions. The
PCRs were performed in a Techne TC-312 cycler (Thermal
Cyclers, Staffordshire, UK) for both reactions with 25 cycles of
95uC for 30 s, 50/53uC for 30 s, 72uC for 1 min and a final extension
72uC for 5 min. The annealing temperatures were 50uC and 53uC for
the external and internal PCRs, respectively.
High-throughput sequence analysis. PCR products were purified
using a QIAquick PCR Purification Kit and quantified using a
QubitH 2.0 Fluorometer (Invitrogen). Prior to sequencing the
amplicons were assessed for fragment concentration using an Ion
Library Quantitation Kit (LifeTechnologiesTM, USA), and concen-
trations were then adjusted to 26 pM. Amplicons were attached to
Ion Sphere Particles (ISPs) using an Ion PGMTM Template OT2
200 kit (LifeTechnologiesTM, USA) according to the manufacturer’s
instructions. Multiplexed sequencing was conducted using a 316TM
chip (LifeTechnologiesTM) on an Ion Torrent Personal Genome
Machine (LifeTechnologiesTM). Sequences were binned by sample
and filtered within the PGM software to remove low quality reads.
Data were then exported as FastQ files.
Taxonomic analyses of sequence reads were performed after the
removal of low quality scores (Q score ,20) with FASTX-Toolkit
(Hannon Lab, USA). Sequences were concatenated and sorted by
sequence similarity into a single fasta file. Sequences were denoised
and analyzed with QIIME73. Briefly, OTU mapping was performed
using the USEARH quality filter pipeline20, to remove putatively
erroneous reads (chimeras), then OTU picking was achieved with
a minimum pairwise identity of 97%. The most abundant sequence
in each OTUwere selected to assign a taxonomic classification based
on the Greengenes database74 using the RDP classifier75, clustering
the sequences at 97% similarity with a 0.80 confidence threshold.
PyNast was used to create a multiple alignment of the representative
sequences for each OTU76 with minimum sequence length threshold
of 120 bp and 97% identification. Sequences were filtered to remove
outliers and filter positions with gaps (0.95) and singletons. Highest
homologous species were identified at 97% and 120 bp using the
resulting consensus sequences in CLC Bio Genomics Workbench
v6.0.4 (QIAGEN, CLC Inc, Aarhus, Denmark) against the 16S
microbial BLAST-NCBI database from 04/22/2013, after a de novo
assembling with default parameters except that 80 bpwas used as the
minimum contig length.
Alpha diversity metrics were calculated on rarefied OTU tables
with QIIME to asses sampling depth coverage using observed spe-
cies, phylogenetic diversity (PD), Chao1, Shannon’s diversity index
andGood’s coverage. QIIMEwas also used to calculate Beta diversity
metrics among samples usingweightedUnifrac distances22 and Bray-
Curtis similarity23. The distance matrixes were represented by two
dimensional principal coordinates analysis (PCoA) plots.
High-performance liquid chromatography (HPLC).The total lipid
contents of 300 mg of larvae at 6 dpf were extracted with the
chloroform-methanol method (251 v/v)77. Cholesterol and TAG
were quantified by HPLC-Light Scattering Detector (LSD) analyses
using a LC-10AD VP gradient pump (Shimadzu, Kyoto, Japan), a
VisionHT Silica 3 mm column (150 3 2.1 mm i.d., Grace Davison
Discovery Science, Deerfield, IL, USA) and a LSD (Sedex 55,
S.E.D.E.RE., France), operating at 40uC and nitrogen pressure of
240 kPa. The chromatograms were acquired and the data handled
using the Class-VP software (Shimadzu). A binary gradient system
composed of hexane [eluent A] and 2-propanol [eluent B] was used
following the solvent elution profile: 0 min 100%A, 10 min 90%A,
15 min 80%A, 20–30 min 100%A. The flow rate was 400 mL min21.
Identification of cholesterol and TAG in the samples was carried out
by comparison of their retention time with those of the respective
commercial standards. Repeated injections of standard solutions
were carried out to test the analytical precision. The relative
standard deviations were less than 5% for all the analyses, both
considering the intradie precision, calculated on six repeated
injections, and the interdie precision, evaluated over six days.
Calibration curves, drawn for each lipid standard by injecting
different concentrations (5–40 mg mL21), were used to quantify
cholesterol, cholesteryl esters and TAG in the fish samples. All the
HPLC analyses were carried out in triplicate. Cholesterol ($99%)
and glyceryl trioleate ($99%) were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Hexane and 2-propanol were of high-
performance liquid chromatography (HPLC) grade and were
obtained from Merck (Darmstadt, Germany). The data obtained
have been normalized to DNA content.
Transmission ElectronMicroscopy (TEM). Samples of 10 zebrafish
larvae at 6 dpf were fixed with 1% potassium dichromate, 1%
osmium tetroxide and 2% glutaraldehyde in cacodylate buffer
(0.1 M, pH 7.2) for 5 hours at 4uC. Samples were washed four
times with cacodylate buffer for 12 hours at 4uC, then dehydrated
with a graded acetone series (from 50% to 100%) and embedded in
epon-based resin. All reagents were purchased fromAGAR Scientific
(UK). The thin (1 mm) and ultrathin sections (60–80 nm) were
obtained with a Reichert Ultracut ultramicrotome using a diamond
knife and were collected on glass slides or copper grids. The thin
sections were stained with 1% toluidine blue and images were
captured using a computer-assisted image analysis system which
includes a Zeiss microscope equipped with a colour video camera
(Axio Cam MRC, Arese Milano Italy). The ultrathin sections were
stained with 1% uranyl acetate and Reynolds lead citrate and then
observed by TEM (JEOL 1200 EXII, JEOL Tokyo, Japan).
Micrographs were acquired with an Olympus SIS VELETA CCD
camera equipped with the iTEM software. Microvilli lengths,
enterocyte lengths and lipid droplet diameters were determined
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from 10 fish per group; 6 images were taken for each intestine and 12
microvilli and enterocytes were measured per image. Enterocyte
lengths were measured starting from their basal membrane
connected with lamina propria up to the base of microvilli, while
microvilli weremeasured starting from their base to the apical tip. All
measurements were taken from micrographs using Software Image
J78. In all cases, measurements were made using sections in which
enterocytes were cut in their entire length, with the nuclei visible and
aligned, to ensure that the section plane was appropriate.
BODIPY 505/515 staining. Fifteen larvae at 6 dpf were placed into
12-well plastic dishes (3 larvae per well) and soaked in 100 mM
BODIPY 505/515 (4,4-Difluoro-1,3,5,7-Tetramethyl-4-Bora-3a,4a-
Diaza-s-Indacene) (Invitrogen) diluted in 2% DMSO, then
incubated for 1 hour at 28uC in the dark. Larvae were
anaesthetized using MS222 (100 mg L21) (Sigma- Aldrich, Milan,
Italy) and fluorescent images were obtained by a Bio-Rad MRC
1024 confocal microscope (Bio-Rad Microscience Ltd, Bio-Rad
House, Hemel Hempstead, UK); equipped with a 103 objective.
Bodipy 505/515 was excited at 505 nm (blue light) and emitted a
spectrum of wavelength light which peaked at 515 nm. Regions of
Interest (ROI) of 15 galbladders and 15 intestines per group were
selected. Fluorescence intensity (arbitrary units a.u.) was determined
using Image J software.
Morphological analysis. At each time point larval length was
measured using a Stemi 2000 micrometric Microscope (Zeiss
Vision Italia, Castiglione Orona, Italy) and weight was determined
using a Microbalance (OHAUS Explorer E11140, Pine Brook, NJ,
USA).
Statistical analysis. Results were expressed as the mean 6 s.d.
Statistical differences were determined using ANOVA, followed by
Bonferroni’s multiple comparison test. All statistical analyses were
performed using Prism 6 (GraphPad Software, SanDiego, CA, USA).
A t-test was used to identify significant differences in relative
abundance of bacterial taxa. P-values ,0.05 were considered
significant.
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